BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38347337)

  • 1. PANoptosis subtypes predict prognosis and immune efficacy in gastric cancer.
    Liu Z; Sun L; Peng X; Zhu J; Wu C; Zhu W; Huang C; Zhu Z
    Apoptosis; 2024 Jun; 29(5-6):799-815. PubMed ID: 38347337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of PANoptosis-related subtypes, construction of a prognosis signature, and tumor microenvironment landscape of hepatocellular carcinoma using bioinformatic analysis and experimental verification.
    Ouyang G; Li Q; Wei Y; Dai W; Deng H; Liu Y; Li J; Li M; Luo S; Li S; Liang Y; Pan G; Yang J; Gan T
    Front Immunol; 2024; 15():1323199. PubMed ID: 38742112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive analysis of PANoptosome to prognosis and immunotherapy response in pan-cancer.
    Zhuang L; Sun Q; Huang S; Hu L; Chen Q
    Sci Rep; 2023 Mar; 13(1):3877. PubMed ID: 36890219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PANoptosis-related signature indicates the prognosis and tumor immune infiltration features of gliomas.
    Song J; Xu Z; Fan Q; Sun Y; Lin X
    Front Mol Neurosci; 2023; 16():1198713. PubMed ID: 37501725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunogenic cell death-related signature predicts prognosis and immunotherapy response in stomach adenocarcinoma.
    Liu Z; Sun L; Peng X; Liu S; Zhu Z; Huang C
    Apoptosis; 2023 Dec; 28(11-12):1564-1583. PubMed ID: 37580435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PANoptosis-related molecular subtype and prognostic model associated with the immune microenvironment and individualized therapy in pancreatic cancer.
    Zhang B; Huang B; Zhang X; Li S; Zhu J; Chen X; Song H; Shang D
    Front Oncol; 2023; 13():1217654. PubMed ID: 37519797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Subtypes Based on PANoptosis Genes and Characteristics of Immune Infiltration in Cutaneous Melanoma.
    Zhong L; Qian W; Gong W; Zhu L; Wang X
    Cell Mol Biol (Noisy-le-grand); 2023 Aug; 69(8):1-8. PubMed ID: 37715443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of molecular subtypes based on PANoptosis-related genes and construction of a signature for predicting the prognosis and response to immunotherapy response in hepatocellular carcinoma.
    Zhu J; Huang Q; Peng X; Luo C; Liu Z; Liu D; Yuan H; Yuan R; Cheng X
    Front Immunol; 2023; 14():1218661. PubMed ID: 37662906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cancer-associated fibroblast-related signature predicts prognosis and indicates immune microenvironment infiltration in gastric cancer.
    Mak TK; Li X; Huang H; Wu K; Huang Z; He Y; Zhang C
    Front Immunol; 2022; 13():951214. PubMed ID: 35967313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of PANoptosis patterns predicts survival and immunotherapy response in gastric cancer.
    Pan H; Pan J; Li P; Gao J
    Clin Immunol; 2022 May; 238():109019. PubMed ID: 35470064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of N7-methylguanosine related subtypes and construction of prognostic model in gastric cancer.
    Li X; Dong H; Chen L; Wang Y; Hao Z; Zhang Y; Jiao Y; Zhao Z; Peng X; Zhan X
    Front Immunol; 2022; 13():984149. PubMed ID: 36300121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression patterns and immunological characterization of PANoptosis -related genes in gastric cancer.
    Qing X; Jiang J; Yuan C; Xie K; Wang K
    Front Endocrinol (Lausanne); 2023; 14():1222072. PubMed ID: 37664853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Analyses of PANoptosome with Potential Implications in Cancer Prognosis and Immunotherapy.
    Cai Y; Xiao H; Zhou Q; Lin J; Liang X; Xu W; Cao Y; Zhang X; Wang H
    Biochem Genet; 2024 Mar; ():. PubMed ID: 38436818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a necroptosis-related gene prognostic score to predict prognosis and efficiency of immunotherapy in gastric cancer.
    Xia Y; Zhang R; Wang M; Li J; Dong J; He K; Guo T; Ju X; Ru J; Zhang S; Sun Y
    Front Immunol; 2022; 13():977338. PubMed ID: 36159818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel PANoptosis-related long non-coding RNA index to predict prognosis, immune microenvironment and personalised treatment in hepatocellular carcinoma.
    Wang L; Wan P; Xu Z
    Aging (Albany NY); 2024 Jan; 16(3):2410-2437. PubMed ID: 38284890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of PANoptosis-related predictors for prognosis and tumor microenvironment by multiomics analysis in glioma.
    Sun F; Liao M; Tao Z; Hu R; Qin J; Tao W; Liu W; Wang Y; Pi G; Lei J; Bao W; Dong Z
    J Cancer; 2024; 15(9):2486-2504. PubMed ID: 38577605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Immune Subtypes and Landscape of Gastric Cancer and to Predict Based on the Whole-Slide Images Using Deep Learning.
    Chen Y; Sun Z; Chen W; Liu C; Chai R; Ding J; Liu W; Feng X; Zhou J; Shen X; Huang S; Xu Z
    Front Immunol; 2021; 12():685992. PubMed ID: 34262565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-
    Chen Q; Du X; Hu S; Huang Q
    Biomed Res Int; 2022; 2022():5092505. PubMed ID: 35036435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of PANoptosis-related signature reveals immune infiltration characteristics and immunotherapy responses for renal cell carcinoma.
    Xu Y; Hua J; Que H; Zeng T; Li Q; Deng J; Xie J
    BMC Cancer; 2024 Mar; 24(1):292. PubMed ID: 38439022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.